🇺🇸 FDA
Patent

US 8815212

Nanocarriers for imaging and therapy applications

granted A61KA61K47/06A61K47/24

Quick answer

US patent 8815212 (Nanocarriers for imaging and therapy applications) held by The Board of Regents of the University of Texas System expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K47/06, A61K47/24, A61K47/30, A61K47/42